세계의 외과용 봉합사 시장 : 제품별, 유형별, 용도별, 최종 사용자별, 지역별 예측(-2030년)

The global surgical sutures market is projected to reach USD 6.65 billion by 2030 from USD 4.84 billion in 2025, at a CAGR of 6.5% during the forecast period."

The growth in the global surgical procedures landscape can be attributed primarily to the increasing prevalence of chronic conditions associated with an aging demographic, notably diabetes, cardiovascular diseases, and musculoskeletal disorders, all of which frequently necessitate surgical intervention. Furthermore, the rising incidence of trauma and accidents contributes to an uptick in suture demand. Innovations such as absorbable, antibacterial, and barbed sutures significantly improve surgical outcomes and mitigate infection risks, thereby catalyzing market growth. Additionally, the ascent of robotic and minimally invasive surgical techniques, which require advanced suturing methodologies, continues to propel the market forward, highlighting the need for precision in wound closure.

"By product, the suture threads segment had the largest market share in the surgical sutures market in 2024."

Suture thread is a critical component for wound closure across various surgical disciplines, thereby securing a substantial share of the surgical sutures market. It plays a vital role in traditional open surgeries and minimally invasive techniques, serving as the cornerstone of any suturing system. The thread's dominance can be attributed to its versatility, the diverse selection of available materials, and ongoing innovations to enhance its performance and efficacy. Advanced suture threads-such as absorbable, non-absorbable, antibacterial-coated, and barbed varieties-have significantly broadened their applicability in general, orthopedic, gynecological, and cardiovascular surgery. Surgeons prefer threads that exhibit high tensile strength, minimal tissue reactivity, and predictable absorption rates. In response, leading manufacturers continually refine these properties to meet the evolving demands of the surgical landscape.

"By type, the multifilament sutures segment held the largest share in the surgical sutures market in 2024."

The surgical suture market is predominantly characterized by multifilament sutures, owing to their superior handling properties, enhanced knot security, and adaptability across various surgical domains. Comprising multiple braided or twisted strands, multifilament sutures exhibit greater strength and pliability than monofilament options, making them particularly well-suited for precise tissue approximation procedures. Their ease of manipulation and excellent knot retention are crucial in minimizing surgical time, a significant advantage in high-demand operating environments. Furthermore, the soft and flexible nature of multifilament sutures minimizes tissue irritation, rendering them ideal for intricate surgical interventions, including gastrointestinal, cardiovascular, and gynecological operations.

"The US is expected to grow at the highest CAGR in the North American surgical sutures market during the study period."

The increasing number of surgical procedures can be primarily attributed to two significant factors: an aging population and a high prevalence of chronic health conditions such as diabetes, obesity, and cardiovascular diseases. These conditions often necessitate surgical intervention to manage complications and improve patients' quality of life. As the demographic landscape shifts with a growing elderly population, healthcare systems face heightened demand for surgical solutions. In addition to these demographic trends, the US boasts a sophisticated healthcare infrastructure that includes extensive hospital networks and improved access to surgical care. This accessibility has led to a rise in the number of surgeries performed, reflecting a broader shift towards proactive healthcare management. Moreover, the US is recognized as a hub for medical innovation, largely due to the presence of leading companies like Ethicon and Medtronic. These firms are at the forefront of developing advanced surgical sutures to enhance patient outcomes. Their offerings include innovative products such as absorbable sutures, which eliminate the need for removal; barbed sutures, which simplify the surgical process by allowing for secure tissue closure without the need for knots; and antibacterial-coated sutures, which help reduce the risk of postoperative infections. The continuous introduction of these cutting-edge suture technologies plays a crucial role in the evolving landscape of surgical procedures. It underscores the commitment to improving surgical techniques and patient care in the US.

A breakdown of the primary participants (supply-side) for the surgical sutures market referred to in this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
• By Designation: C-level-45%, Director Level-35%, and Others-20%
• By Region: North America-27%, Europe-25%, Asia Pacific-30%, Latin America- 8%, Middle East & Africa-10% .

Prominent players in the surgical sutures market are Ethicon [Johnson & Johnson] (US), Medtronic (Ireland), B.Braun SE (Germany), Advanced Medical Solutions Group Plc (UK), Healthium MedTech Limited (India), Boston Scientific Corporation (US) Zimmer Biomet Holdings, Inc. (US), Stryker (US), Smith+Nephew (UK), Conmed Corporation (US), Internacional Farmaceutica S.A. de C.V. (Mexico), Corza Medical (US), DemeTECH Corporation (US), Unisur Lifecare Pvt. Ltd (India), Assut Europe (Italy), RESORBA Medical GmbH (Germany), KATSAN Katgut Sanayi ve Tic. A.S. (Turkey), Sutumed Corp. (US), Mellon Medical (Netherlands), Futura Surgicare Pvt. Ltd. (India), GMD Group (Turkey), Lotus Surgicals Pvt Ltd (India), BioSintex (Romania), Meril Life Sciences Pvt. Ltd. (India), and Aqmen Medtech (India).

Research Coverage:

The report analyzes the surgical sutures market and aims to estimate the market size and future growth potential based on various segments such as product, type, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help market leaders and new entrants by providing information on the closest approximations of the revenue numbers for the surgical sutures market. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing number of surgical procedures, rising incidence of trauma-related cases, growing medical tourism industry, rising incidence of chronic lifestyle-related diseases, advancements in surgical sutures), restraints (increasing preference for minimally invasive surgeries, presence of alternative wound care management products), opportunities (growth opportunities in low- and middle-income countries) and challenges (market saturation and pricing pressure).
• Market Penetration: It includes extensive information on products the major players in the global surgical sutures market offers. The report includes various product, type, application, end user, and region segments.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global surgical sutures market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, application, end user, and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global surgical sutures market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global surgical sutures market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 ASSUMPTIONS & LIMITATIONS
  • 2.5.1 STUDY ASSUMPTIONS
  • 2.5.2 LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SURGICAL SUTURES MARKET OVERVIEW
• 4.2 ASIA PACIFIC: SURGICAL SUTURES MARKET, BY PRODUCT & TYPE
• 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 REGIONAL MIX: SURGICAL SUTURES MARKET
• 4.5 SURGICAL SUTURES MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing number of surgical procedures
    • 5.2.1.2 Growing number of trauma cases
    • 5.2.1.3 Growing medical tourism industry
    • 5.2.1.4 Rising incidence of chronic lifestyle-related diseases
    • 5.2.1.5 Advancements in surgical sutures
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Increasing preference for minimally invasive surgeries
    • 5.2.2.2 Presence of alternative wound care management products
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth opportunities in LMICs
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Market saturation and pricing pressure
• 5.3 REGULATORY LANDSCAPE
  • 5.3.1 REGULATORY FRAMEWORK
    • 5.3.1.1 North America
      • 5.3.1.1.1 US
      • 5.3.1.1.2 Canada
    • 5.3.1.2 Europe
  • 5.3.2 ASIA PACIFIC
    • 5.3.2.1 Japan
    • 5.3.2.2 China
    • 5.3.2.3 India
  • 5.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Sutures with integrated sensors for detecting infection
    • 5.4.1.2 Drug-eluting sutures for local therapeutic delivery
    • 5.4.1.3 Barbed sutures
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Surgical robots
    • 5.4.2.2 Surgical staplers and clips
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 Bioengineered suture materials
    • 5.4.3.2 AI-driven surgical assistance
• 5.5 INDUSTRY TRENDS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 SUPPLY CHAIN ANALYSIS
• 5.8 TRADE ANALYSIS
  • 5.8.1 IMPORT DATA FOR HS CODE 300610
  • 5.8.2 EXPORT DATA FOR HS CODE 300610
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER, 2024
  • 5.9.2 AVERAGE SELLING PRICE, BY REGION, 2024
• 5.10 PORTER'S FIVE FORCES ANALYSIS
  • 5.10.1 THREAT OF NEW ENTRANTS
  • 5.10.2 THREAT OF SUBSTITUTES
  • 5.10.3 BARGAINING POWER OF SUPPLIERS
  • 5.10.4 BARGAINING POWER OF BUYERS
  • 5.10.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.11 ADJACENT MARKET ANALYSIS
• 5.12 PATENT ANALYSIS
• 5.13 ECOSYSTEM ANALYSIS
• 5.14 KEY CONFERENCES & EVENTS, 2025-2026
• 5.15 CASE STUDIES
  • 5.15.1 CASE STUDY 1: UNIVERSITY RESEARCHERS DEVELOP REAL-TIME NON-INVASIVE WOUND MONITORING
  • 5.15.2 CASE STUDY 2: ORTHOPEDIC INNOVATION AND PATIENT OUTCOMES
  • 5.15.3 CASE STUDY 3: REDUCING SURGICAL SITE INFECTIONS WITH VICRYL PLUS
• 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.17 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.17.2 BUYING CRITERIA
• 5.18 INVESTMENT & FUNDING SCENARIO
• 5.19 UNMET NEEDS/ END-USER EXPECTATIONS
• 5.20 IMPACT OF AI ON SURGICAL SUTURES MARKET
• 5.21 IMPACT OF 2025 US TARIFFS-SURGICAL SUTURES MARKET
  • 5.21.1 INTRODUCTION
  • 5.21.2 KEY TARIFF RATES
  • 5.21.3 PRICE IMPACT ANALYSIS
  • 5.21.4 IMPACT ON COUNTRIES/REGIONS
    • 5.21.4.1 US
    • 5.21.4.2 Europe
    • 5.21.4.3 Asia Pacific
  • 5.21.5 IMPACT ON END-USER INDUSTRIES

6 SURGICAL SUTURES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 SUTURE THREADS
  • 6.2.1 BY NATURE OF ABSORBENT
    • 6.2.1.1 Absorbable sutures
      • 6.2.1.1.1 Absorbable synthetic sutures
        • 6.2.1.1.1.1 Polyglactin 910 sutures
          • 6.2.1.1.1.1.1 High rigidity and knot strength of polyglactin 910 sutures to drive demand
        • 6.2.1.1.1.2 Poliglecaprone 25 sutures
          • 6.2.1.1.1.2.1 Smooth surface area and minimal tissue reaction to boost adoption
        • 6.2.1.1.1.3 Polydioxanone sutures
          • 6.2.1.1.1.3.1 Long-duration wound support and superior strength of polydioxanone sutures to drive growth
        • 6.2.1.1.1.4 Polyglycolic acid sutures
          • 6.2.1.1.1.4.1 Superior elasticity and strength compared to other braided structures to support market growth
        • 6.2.1.1.1.5 Other absorbable synthetic sutures
      • 6.2.1.1.2 Absorbable natural sutures
        • 6.2.1.1.2.1 Catgut plain sutures
          • 6.2.1.1.2.1.1 Fast-absorbing properties to boost demand
        • 6.2.1.1.2.2 Catgut chromic sutures
          • 6.2.1.1.2.2.1 Ability to absorb more rapidly in affected tissues to boost adoption
    • 6.2.1.2 Non-absorbable sutures
      • 6.2.1.2.1 Non-absorbable synthetic sutures
        • 6.2.1.2.1.1 Nylon sutures
          • 6.2.1.2.1.1.1 Growing use of nylon sutures in general soft tissue approximation to boost market
        • 6.2.1.2.1.2 Polypropylene sutures
          • 6.2.1.2.1.2.1 High tensile strength and flexibility of polypropylene sutures to fuel growth
        • 6.2.1.2.1.3 Stainless steel sutures
          • 6.2.1.2.1.3.1 Growing use of stainless steel sutures in hernia and tendon repair to support market growth
        • 6.2.1.2.1.4 UHMWPE sutures
          • 6.2.1.2.1.4.1 Non-reactive nature of UHMWPE sutures to boost demand
        • 6.2.1.2.1.5 Other non-absorbable synthetic sutures
      • 6.2.1.2.2 Non-absorbable natural sutures
        • 6.2.1.2.2.1 Cotton sutures
          • 6.2.1.2.2.1.1 Growing applications of cotton sutures in healthcare and cosmetic procedures to boost market
        • 6.2.1.2.2.2 Silk sutures
          • 6.2.1.2.2.2.1 Good tensile strength offered by silk sutures to support growth
        • 6.2.1.2.2.3 Other non-absorbable natural sutures
  • 6.2.2 BY COATING
    • 6.2.2.1 Uncoated sutures
      • 6.2.2.1.1 High risk of infection associated with uncoated sutures to restrict market growth
    • 6.2.2.2 Antimicrobial-coated sutures
      • 6.2.2.2.1 High burden of SSIs to drive adoption
    • 6.2.2.3 Other coated sutures
• 6.3 AUTOMATED SUTURING DEVICES
  • 6.3.1 DISPOSABLE AUTOMATED SUTURING DEVICES
    • 6.3.1.1 Lower cost compared to reusable devices to boost market
  • 6.3.2 REUSABLE AUTOMATED SUTURING DEVICES
    • 6.3.2.1 Customizability and lower overall expenses to support market growth

7 SURGICAL SUTURE THREADS MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 MULTIFILAMENT SUTURES
  • 7.2.1 MULTIFILAMENT SUTURES TO ACCOUNT FOR LARGEST MARKET SHARE
• 7.3 MONOFILAMENT SUTURES
  • 7.3.1 LOW KNOT SECURITY AND LESS FLEXIBILITY TO RESTRICT GROWTH

8 SURGICAL SUTURES MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 CARDIOVASCULAR SURGERY
  • 8.2.1 GROWING ADOPTION OF POLYPROPYLENE SUTURES IN CARDIOVASCULAR PROCEDURES TO BOOST MARKET
• 8.3 GENERAL SURGERY
  • 8.3.1 NEED TO PREVENT BLOOD LOSS IN GASTROINTESTINAL SURGERIES TO DRIVE ADOPTION
• 8.4 GYNECOLOGICAL SURGERY
  • 8.4.1 HIGH PROCEDURAL VOLUME TO ENSURE STRONG DEMAND
• 8.5 ORTHOPEDIC SURGERY
  • 8.5.1 INCREASING PREVALENCE OF SPORTS-RELATED INJURIES TO SUPPORT MARKET GROWTH
• 8.6 OPHTHALMIC SURGERY
  • 8.6.1 HIGH NUMBER OF OPHTHALMIC PROCEDURES PERFORMED TO FAVOR MARKET GROWTH
• 8.7 COSMETIC & PLASTIC SURGERY
  • 8.7.1 GROWING NUMBER OF COSMETIC & PLASTIC SURGERIES TO DRIVE ADOPTION OF SUTURES
• 8.8 OTHER APPLICATIONS

9 SURGICAL SUTURES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 INCREASING NUMBER OF SURGERIES AND TRAUMA CASES TO DRIVE ADOPTION OF SURGICAL SUTURES AMONG HOSPITALS
• 9.3 AMBULATORY SURGICAL CENTERS
  • 9.3.1 GROWING NUMBER OF SURGICAL PROCEDURES PERFORMED IN ASCS TO FAVOR MARKET GROWTH
• 9.4 CLINICS & PHYSICIAN OFFICES
  • 9.4.1 WIDE RANGE OF MEDICAL SERVICES TO SUPPORT GROWTH

10 SURGICAL SUTURES MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American surgical sutures market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Improving healthcare quality and government support to aid market growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Germany to dominate market for surgical sutures in Europe
  • 10.3.3 UK
    • 10.3.3.1 Rising incidence and prevalence of CVD to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 High healthcare spending by government to drive adoption of surgical sutures
  • 10.3.5 ITALY
    • 10.3.5.1 Improving quality of and accessibility to medical care and technologies to boost market
  • 10.3.6 SPAIN
    • 10.3.6.1 Increasing incidence of cardiovascular diseases to favor market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 China to dominate market for surgical sutures in APAC
  • 10.4.3 INDIA
    • 10.4.3.1 Large number of surgical procedures performed to drive market growth
  • 10.4.4 JAPAN
    • 10.4.4.1 Early adoption of technologically advanced products to drive market growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Increasing incidence of obesity and rising number of bariatric surgeries to aid market growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 High geriatric population and increased surgical procedures to propel market growth
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 High diabetes rates and focus on private-public partnerships for better healthcare facilities to favor market growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Increased focus on medical tourism and developed private healthcare sector to drive market
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Higher disposable income and increased government healthcare expenditure to propel market growth
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SURGICAL SUTURES MARKET
• 11.3 REVENUE ANALYSIS, 2022-2025
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Type footprint
    • 11.5.5.5 Application footprint
    • 11.5.5.6 End-user footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 DYNAMIC COMPANIES
  • 11.6.3 STARTING BLOCKS
  • 11.6.4 RESPONSIVE COMPANIES
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.6.5.1 Detailed list of key startups/SMEs
    • 11.6.5.2 Competitive benchmarking of key startups/SMEs
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7.1 FINANCIAL METRICS
  • 11.7.2 COMPANY VALUATION
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES
  • 11.9.2 DEALS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 ETHICON, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON)
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 MEDTRONIC
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Right to win
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 B. BRAUN SE
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 MnM view
      • 12.1.3.3.1 Right to win
      • 12.1.3.3.2 Strategic choices
      • 12.1.3.3.3 Weaknesses & competitive threats
  • 12.1.4 ADVANCED MEDICAL SOLUTIONS GROUP PLC (AMS GROUP)
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Right to win
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 HEALTHIUM MEDTECH LIMITED
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches
      • 12.1.5.3.2 Deals
      • 12.1.5.3.3 Expansions
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Right to win
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 BOSTON SCIENTIFIC CORPORATION
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Deals
  • 12.1.7 ZIMMER BIOMET HOLDINGS, INC.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Deals
  • 12.1.8 STRYKER
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
  • 12.1.9 SMITH+NEPHEW
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
  • 12.1.10 CONMED CORPORATION
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
  • 12.1.11 INTERNACIONAL FARMACEUTICA S.A. DE C.V.
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
  • 12.1.12 CORZA MEDICAL
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Product launches
  • 12.1.13 DEMETECH CORPORATION
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
  • 12.1.14 UNISUR LIFECARE PVT. LTD
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
  • 12.1.15 ASSUT EUROPE
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 RESORBA MEDICAL GMBH
  • 12.2.2 KATSAN KATGUT SANAYI VE TIC. A.S.
  • 12.2.3 SUTUMED CORP.
  • 12.2.4 FUTURA SURGICARE PVT. LTD.
  • 12.2.5 GMD GROUP
  • 12.2.6 LOTUS SURGICALS PVT LTD
  • 12.2.7 BIOSINTEX
  • 12.2.8 MERIL LIFE SCIENCES PVT. LTD.
  • 12.2.9 MELLON MEDICAL
  • 12.2.10 AQMEN MEDTECH
  • 12.2.11 ANCHORA MEDICAL LTD.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS